Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hinton

Showing results (241-250 of 262) with videos related to

Pageof 27
Sort By:
Journal of Medicinal Chemistry|April 17, 1998
Novel nonpeptide CCK-B antagonists: design and development of quinazolinone derivatives as potent, selective, and orally active CCK-B antagonistsJ K Padia, M Field, J Hinton, et al.
American Journal of Medical Genetics|April 1, 1992
Mode of inheritance influences behavioral expression and molecular control of cognitive deficits in female carriers of the fragile X syndromeV J Hinton, C S Dobkin, J M Halperin, et al.
Neuropharmacology|December 12, 2017
Neurogranin in the nucleus accumbens regulates NMDA receptor tolerance and motivation for ethanol seekingAshlie N Reker, Alfredo Oliveros, John M Sullivan, et al.
American Journal of Medical Genetics|December 18, 1995
Adult fragile X syndrome: neuropsychology, brain anatomy, and metabolismM B Schapiro, D G Murphy, R J Hagerman, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2009
Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cellsCaroline E von Allmen, Nicole Schmitz, Monika Bauer, et al.
Proteomics|February 14, 2018
Pharmacoproteomics Profile in Response to Acamprosate Treatment of an Alcoholism Animal ModelCaroline E Germany, Ashlie N Reker, David J Hinton, et al.
Nature Communications|May 12, 2026
Artificial intelligence for predicting hospital admissions from the emergency department: a prospective, quasi-experimental studyAlexander J Ryu, Shant Ayanian, Ray Qian, et al.
Translational Psychiatry|August 19, 2015
Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjectsH W Nam, V M Karpyak, D J Hinton, et al.
Proteomics. Clinical Applications|September 28, 2011
Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexesEarle F Burgess, Amy-Joan L Ham, David L Tabb, et al.
Molecular and Cellular Biology|November 17, 2005
Generation and characterization of p38beta (MAPK11) gene-targeted miceVictoria A Beardmore, Heather J Hinton, Christina Eftychi, et al.
Pageof 27

Showing results (241-250 of 262) with videos related to

Sort By:
Pageof 27
Journal of Medicinal Chemistry|April 17, 1998
Novel nonpeptide CCK-B antagonists: design and development of quinazolinone derivatives as potent, selective, and orally active CCK-B antagonistsJ K Padia, M Field, J Hinton, et al.
American Journal of Medical Genetics|April 1, 1992
Mode of inheritance influences behavioral expression and molecular control of cognitive deficits in female carriers of the fragile X syndromeV J Hinton, C S Dobkin, J M Halperin, et al.
Neuropharmacology|December 12, 2017
Neurogranin in the nucleus accumbens regulates NMDA receptor tolerance and motivation for ethanol seekingAshlie N Reker, Alfredo Oliveros, John M Sullivan, et al.
American Journal of Medical Genetics|December 18, 1995
Adult fragile X syndrome: neuropsychology, brain anatomy, and metabolismM B Schapiro, D G Murphy, R J Hagerman, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2009
Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cellsCaroline E von Allmen, Nicole Schmitz, Monika Bauer, et al.
Proteomics|February 14, 2018
Pharmacoproteomics Profile in Response to Acamprosate Treatment of an Alcoholism Animal ModelCaroline E Germany, Ashlie N Reker, David J Hinton, et al.
Nature Communications|May 12, 2026
Artificial intelligence for predicting hospital admissions from the emergency department: a prospective, quasi-experimental studyAlexander J Ryu, Shant Ayanian, Ray Qian, et al.
Translational Psychiatry|August 19, 2015
Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjectsH W Nam, V M Karpyak, D J Hinton, et al.
Proteomics. Clinical Applications|September 28, 2011
Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexesEarle F Burgess, Amy-Joan L Ham, David L Tabb, et al.
Molecular and Cellular Biology|November 17, 2005
Generation and characterization of p38beta (MAPK11) gene-targeted miceVictoria A Beardmore, Heather J Hinton, Christina Eftychi, et al.
Pageof 27